MARCO and renal cell carcinoma: We further sorted MARCO+ and MARCO‐ TAMs from RCC tumor tissues and performed transcriptome analyses, which confirmed the downregulation of antigen‐presentation pathway and MHC‐I genes (HLA‐A and HLA‐B) in MARCO+ TAMs (Figure S8A–G, Supporting Information).